Early tick salivary antigens as vaccine targets
Early tick salivary antigens as vaccine targets
批准号:
7140228
负责人:
SUKANYA NARASIMHAN
金额:
$19.65万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2005
资助国家:
美国
项目状态:
已结题
起止时间:
2005-06-15 至 2008-05-31
中文摘要
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Ixodes scapularis, is the arthropod vector for Borrelia burgdorferi, the causative agent of Lyme disease. In addition, the tick serves as a vector for other bacterial, protozoan and viral pathogens. There is an unmet need for safe and effective vaccines against these pathogens. Co-infected ticks can transmit more than one pathogen simultaneously. Vaccines targeting the tick would have the advantage of blocking multiple tick-transmitted diseases. While Anaplasma phagocytophila is transmission commences after about 24 h of tick feeding, B. burgdorferi transmission begins after 24-36 h of tick feeding. To develop vaccines that can block transmission of multiple pathogens, it is crucial to thwart feeding and transmission at the outset of tick feeding. Acquired tick-immunity is a phenomenon wherein repeated infestation of vertebrate hosts results in tick rejection within 12-24 h of tick attachment. Tick-immunity also effectively abrogates transmission of B. burgdorferi. Host immunity directed against tick salivary antigens crucial for establishing tick-feeding contributes to this phenomenon. Acquired tick-immunity that is apparent within the first 24 h of attachment must therefore be directed against early antigens. Research to date has focused largely on tick salivary antigens expressed 3-4 days after tick attachment, with little success. The focus of this proposal is, therefore, to identify tick salivary antigens expressed and secreted in the first 24 h of tick attachment that are targeted by host tick-immunity. It is expected that by defining antigens that evoke tick-immunity, we will identify salivary antigens that can be targeted to effectively block tick feeding at the very outset and consequently block the transmission of pathogens harbored by the tick. The emphasis in this proposal will be on B. burgdorferi transmission. An immunoscreening approach will be taken to identify 24 h tick salivary antigens that react with 24 h nymphimmune serum. The physiological role of these antigens in tick feeding and in B. burgdorferi transmission will be determined using the RNA interference strategy. The antigens will be prioritized based on their role in feeding and Borrelia transmission and vaccine candidates determined. Results obtained will provide the basis for future vaccine development studies.
期刊论文(1)
专著(0)
科研奖励(0)
会议论文
Immunity against Ixodes scapularis salivary proteins expressed within 24 hours of attachment thwarts tick feeding and impairs Borrelia transmission.
附着后 24 小时内表达的针对肩胛硬蜱唾液蛋白的免疫力会阻碍蜱虫进食并损害疏螺旋体传播。
DOI:
10.1371/journal.pone.0000451
发表时间:
2007-05-16
期刊:
PloS one
影响因子:
3.7
作者:
[Narasimhan S, Deponte K, Marcantonio N, Liang X, Royce TE, Nelson KF, Booth CJ, Koski B, Anderson JF, Kantor F, Fikrig E]
通讯作者:
Fikrig E
A therapeutic for Lyme disease based on Peptidoglycan Recognition Protein 1
-
批准号:10461961
-
项目类别:
-
资助金额:$29.95万
-
财政年份:2021
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
A therapeutic for Lyme disease based on Peptidoglycan Recognition Protein 1
-
批准号:10256453
-
项目类别:
-
资助金额:$29.95万
-
财政年份:2021
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Importance of Immunogenic salivary glycans in eliciting resistance to ticks
-
批准号:9386568
-
项目类别:
-
资助金额:$22.19万
-
财政年份:2017
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
A Multivalent Lyme Disease Vaccine Targeting Tick-Host-Pathogen Interactions
-
批准号:8876575
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
A Multivalent Lyme Disease Vaccine Targeting Tick-Host-Pathogen Interactions
-
批准号:8714278
-
项目类别:
-
资助金额:$30.0万
-
财政年份:2014
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Tick Midgut Proteins Critical for Borrelia Transmission
-
批准号:7739244
-
项目类别:
-
资助金额:$20.69万
-
财政年份:2009
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Tick Midgut Proteins Critical for Borrelia Transmission
-
批准号:7860343
-
项目类别:
-
资助金额:$24.83万
-
财政年份:2009
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Characterization of an Anaplasma phagocytophilum protein interfering with eukaryo
-
批准号:7879356
-
项目类别:
-
资助金额:$8.19万
-
财政年份:2009
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Characterization of an Anaplasma phagocytophilum protein interfering with eukaryo
-
批准号:7738737
-
项目类别:
-
资助金额:$8.28万
-
财政年份:2009
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
A NON-HUMAN PRIMATE MODEL OF TICK-IMMUNITY
-
批准号:7716309
-
项目类别:
-
资助金额:$1.39万
-
财政年份:2008
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Cutaneous Contact Hypersensitivity - A Surrogate Model for Tick-Immunity
-
批准号:7608582
-
项目类别:
-
资助金额:$4.73万
-
财政年份:2008
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Tick Midgut Thrombin Inhibitor as a Vaccine Target
-
批准号:7481490
-
项目类别:
-
资助金额:$21.34万
-
财政年份:2008
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Gut Microbiome of P. Leucopus and M. Musculus in the Context of Lyme Arthritis
-
批准号:8720293
-
项目类别:
-
资助金额:$4.15万
-
财政年份:2007
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
A NONHUMAN PRIMATE MODEL OF TICK IMMUNITY
-
批准号:7562397
-
项目类别:
-
资助金额:$1.4万
-
财政年份:2007
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Early tick salivary antigens as vaccine targets
-
批准号:6956344
-
项目类别:
-
资助金额:$23.89万
-
财政年份:2005
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Tick gene expression- in the context of Lyme disease
-
批准号:6877083
-
项目类别:
-
资助金额:$23.89万
-
财政年份:2004
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Tick gene expression- in the context of Lyme disease
-
批准号:6712064
-
项目类别:
-
资助金额:$23.89万
-
财政年份:2004
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Molecular analysis of tick-spirochete interactions
-
批准号:6659778
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2002
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
Molecular analysis of tick-spirochete interactions
-
批准号:6557160
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2002
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
BORRELIA BURGDORFERI GENE EXPRESSION IN TICK MIDGUT--ROL
-
批准号:6512244
-
项目类别:
-
资助金额:$8.18万
-
财政年份:2000
-
负责人:SUKANYA NARASIMHAN
-
依托单位:
海外基金